Media Center

Recent News

04/21/21
Summary ToggleAcadia Pharmaceuticals to Announce First Quarter 2021 Financial Results on May 5, 2021
04/05/21
Summary ToggleAcadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
03/08/21
Summary ToggleAcadia Pharmaceuticals Provides Regulatory Update on Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
02/24/21
Summary ToggleAcadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
02/19/21
Summary ToggleAcadia Pharmaceuticals Recognizes National Caregiver’s Day with Launch of MoreThanMemoryLoss.com
2020 | 2019 | 2018 | Archive